All lobbying filings

RIDGE POLICY GROUP

RIDGE POLICY GROUP filed a Q3 amendment for OCUGEN INC. on November 9, 2026, reporting $30,000 in lobbying income.

Lobbying for OCUGEN INC. · Biotech company

All filings by RIDGE POLICY GROUP · Everything OCUGEN INC. has reported

Filing · LD-2 quarterly report Q3 amendment

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Nov 9, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Government bodies contacted 6

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Health care and innovation issues H.R. 7539 LOANS for Biomedical Research Act Cameron's Law HR 6412 Independence Investment Fund Act

Bills named in this filing 2

H.R. 7539
LOANS for Biomedical Research Act
H.R. 6412
Independence Investment Fund Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.